NCT02893631View on ClinicalTrials.gov

Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 21, 2017

Study Completion Date

December 21, 2017

Conditions
Stroke, Acute
Trial Locations (1)

75019

Fondation Ophtalmologique Adolphe de Rothschild, Paris

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT02893631 - Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke | Biotech Hunter | Biotech Hunter